The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014
Open accessAbstract
Cachexia is a serious but underrecognised consequence of many chronic diseases. Its prevalence ranges from 5–15 % in end‐stage chronic heart failure to 50–80 % in advanced cancer. Cachexia is also part of the terminal course of many patients with chronic kidney disease, chronic obstructive pulmonary disease (COPD) and rheumatoid arthritis. Mortality rates of patients with cachexia range from 10–15 % per year in COPD through 20–30 % per year in chronic heart failure and chronic kidney disease to 80 % in cancer. The condition is also associated with poor quality of life. In the industrialised world, the overall prevalence of cachexia (due to any disease and not necessarily associated with hospital admission) is growing and it currently affects around 1 % of the patient population, i.e. around 9 million people. It is also a significant health problem in other parts of the globe. Recently there have been advances in our understanding of the multifactorial nature of the condition, and particularly of the role of inflammatory mediators and the imbalance of anabolism and catabolism. Several promising approaches to treatment have failed to live up to the challenge of phase III clinical trials, but the ghrelin receptor agonist anamorelin seems to have fulfilled at least some early promise. Further advances are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,680
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Self-citationCancer cachexia: understanding the molecular basis
Argilés, J. M., Busquets, S., Stemmler, B., & López-Soriano, F. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3829 · Cited by 1,517
Fulster, S., Tacke, M., Sandek, A., Ebner, N., Tschope, C., Doehner, W., Anker, S. D., & von Haehling, S. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs381 · Cited by 658
Self-citationCachexia as a major underestimated and unmet medical need: facts and numbers
von Haehling, S., & Anker, S. D. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0002-6 · Cited by 533
Self-citationWallengren, O., Lundholm, K., & Bosaeus, I. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-012-1697-z · Cited by 177
DISEASE OF THE HEART IN THE WORKS OF HIPPOCRATES
Katz, A. M., & Katz, P. B. (1962) · Heart · doi:10.1136/hrt.24.3.257 · Cited by 169
Cachexia as a major public health problem: frequent, costly, and deadly
Farkas, J., von Haehling, S., Kalantar-Zadeh, K., Morley, J. E., Anker, S. D., & Lainscak, M. (2013) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-013-0105-y · Cited by 162
Self-citationMelenovsky, V., Kotrc, M., Borlaug, B. A., Marek, T., Kovar, J., Malek, I., & Kautzner, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.046 · Cited by 162
Bourdel‐Marchasson, I., Blanc-Bisson, C., Doussau, A., Germain, C., Blanc, J., Dauba, J., Lahmar, C., Terrebonne, É., Lecaille, C., Ceccaldi, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108687 · Cited by 140
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citation2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Self-citationGroenewegen, A., Rutten, F. H., Mosterd, A., & Hoes, A. W. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1858 · Cited by 2,043
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0141 · Cited by 444
Self-citation
Metadata
- Authors
- von Haehling, S., & Anker, S. D.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2014-11-11
- Volume
- 5
- Issue
- 4
- Pages
- 261-263
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W2037605387
- Cited by
- 395
- References
- 15
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014. https://app.cochat.ai/papers/10.1007/s13539-014-0164-8
- The paper
- von Haehling, S., & Anker, S. D. (2014). Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1007/s13539-014-0164-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.